特布他林联合布地奈德雾化吸入治疗慢性阻塞性肺疾病的临床分析

Clinical Analysis of Atorvastatin Combined With Budesonide Inhalation Therapy for Chronic Obstructive Pulmonary Disease

目的探讨特布他林联合布地奈德雾化吸入治疗慢性阻塞性肺疾病的临床效果。方法选取我院收治的慢性阻塞性肺疾病患者88例作为研究对象。并将其随机分为治疗组(n=44)与对照组(n=44)。治疗组采取特布他林联合布地奈德雾化吸入治疗,对照组采用常规应用甲强龙静滴治疗,对比两组患者疗效、肺功能指标进行统计学对比。结果 (1)治疗组患者治疗总有效率为97.7%,高于对照组(86.4%),差异具有统计学意义(P<0.05);(2)治疗组治疗后的肺功能指标FVC、FEV1均优于对照组,差异均具有统计学意义(P均<0.01)。结论特布他林联合布地奈德雾化吸入治疗慢性阻塞性肺疾病的临床效果肯定,并能改善肺功能。

Objective To investigate the clinical effect of terbutaline combined with budesonide inhalation in the treatment of chronic obstructive pulmonary disease. Methods 88 cases of chronic obstructive pulmonary disease in our hospital were selected as the research object. The patients were randomly divided into treatment group （n=44） and control group （n=44）. The treatment group was treated with terbutaline combined with budesonide inhalation, the control group was treated with routine intravenous drip of methylprednisolone, the efficacy and pulmonary function indexes of the two groups were compared statistically. Results （1） The total effective rate was 97.7% in the treatment group, which was higher than that in the control group （86.4%）, the difference was statistically significant （P〈0.05）. （2） The lung function indexes FVC and FEV1 in the treatment group were better than those in the control group, the difference was statistically significant （P〈0.01）. Conclusion The clinical effect of terbutaline combined with budesonide inhalation therapy for chronic obstructive pulmonary disease is positive and can improve lung function.